Ventyx Biosciences Inc (VTYX)
4.90
-0.01
(-0.20%)
USD |
NASDAQ |
May 03, 15:29
Ventyx Biosciences Market Cap: 290.27M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 290.86M |
| May 01, 2024 | 277.24M |
| April 30, 2024 | 221.55M |
| April 29, 2024 | 227.18M |
| April 26, 2024 | 232.81M |
| April 25, 2024 | 240.51M |
| April 24, 2024 | 251.17M |
| April 23, 2024 | 257.69M |
| April 22, 2024 | 254.73M |
| April 19, 2024 | 264.80M |
| April 18, 2024 | 257.69M |
| April 17, 2024 | 259.47M |
| April 16, 2024 | 281.98M |
| April 15, 2024 | 276.65M |
| April 12, 2024 | 272.50M |
| April 11, 2024 | 272.50M |
| April 10, 2024 | 281.39M |
| April 09, 2024 | 298.57M |
| April 08, 2024 | 279.61M |
| April 05, 2024 | 286.72M |
| April 04, 2024 | 290.27M |
| April 03, 2024 | 306.86M |
| April 02, 2024 | 310.41M |
| April 01, 2024 | 331.15M |
| March 28, 2024 | 325.82M |
| Date | Value |
|---|---|
| March 27, 2024 | 343.88M |
| March 26, 2024 | 347.14M |
| March 25, 2024 | 387.42M |
| March 22, 2024 | 396.90M |
| March 21, 2024 | 435.41M |
| March 20, 2024 | 444.29M |
| March 19, 2024 | 467.99M |
| March 18, 2024 | 472.73M |
| March 15, 2024 | 456.14M |
| March 14, 2024 | 459.10M |
| March 13, 2024 | 498.20M |
| March 12, 2024 | 498.79M |
| March 11, 2024 | 476.28M |
| March 08, 2024 | 587.65M |
| March 07, 2024 | 600.09M |
| March 06, 2024 | 530.19M |
| March 05, 2024 | 507.09M |
| March 04, 2024 | 533.15M |
| March 01, 2024 | 503.53M |
| February 29, 2024 | 419.41M |
| February 28, 2024 | 460.29M |
| February 27, 2024 | 358.40M |
| February 26, 2024 | 347.14M |
| February 23, 2024 | 397.49M |
| February 22, 2024 | 341.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
112.55M
Minimum
Jan 18 2024
2.658B
Maximum
Mar 03 2023
1.202B
Average
1.014B
Median
Oct 20 2023
Market Cap Benchmarks
| Anavex Life Sciences Corp | 316.13M |
| CERo Therapeutics Holdings Inc | 14.00M |
| Avinger Inc | 6.545M |
| Checkpoint Therapeutics Inc | 56.92M |
| RAPT Therapeutics Inc | 288.47M |
Market Cap Related Metrics
| Price to Book Value | 1.190 |
| Price | 4.90 |
| Earnings Yield | -67.35% |